5th Annual MarketsandMarkets

Infectious Disease and Molecular Diagnostics Conference

21st – 22nd March 2024

Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH

Implementing advanced technologies in the world of diagnostics.

The healthcare sector is undergoing significant transformations, largely due to advancements in technology, and the Diagnostics field has emerged as a pivotal catalyst in this evolution. Given its crucial role in treatment decisions, diagnostics must strive for speed, precision, and accuracy.

We are pleased to announce the 5th Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference, organized by MarketsandMarkets. This esteemed event is scheduled to take place on the 21st and 22nd of March 2024 in London. The conference has been handcrafted to showcase the latest insights in diagnostics, explore emerging technologies and their applications, address challenges within the diagnostics domain, including diagnostic settings, sample processing, regulations, validations, high costs of advanced technologies, challenges related to blood transfusion technology, and the global need for improved healthcare. It will also delve into topics such as vaccine efficacy, side effects, issues with test kits, and the importance of result accuracy.

This conference promises to attract an impressive gathering of influential healthcare and industry leaders who are shaping the future of the field. Their expertise and vision make them some of the brightest minds on the planet.

CO-LOCATED CONFERENCES

8th Annual MarketsandMarkets Infection Control, Sterilization & Decontamination Conference
3rd Annual MarketsandMarkets Minimally Invasive Surgery Conference
2nd Annual MarketsandMarkets Next - Gen Digital Pathology Conference

WHAT TO EXPECT

Key Sessions on Molecular Diagnostics:


•    Developing a Molecular and Rapid Testing Diagnostic Service
•    The Impact of NGS in Diagnostic Virology Involving HIV-1 Tropism, Genotypic Resistance in Influenza, HBV, Hepatitis C Virus (HCV) and Cytomegalovirus (CMV)
•    Current Molecular Diagnostics and Whole Genome Sequencing (WGS) Applied to Mycobacteria
•    KCL TEST: Matching Results from the ONS and Generating Molecular Biology Laboratory-Based Protocols  
•    Molecular Diagnosis of Drug-Resistant Tuberculosis

Key Sessions on Infectious Diseases:


•    Clinical Validation of a Point-of-Care Multiplexed In Vitro Immunoassay Using Monoclonal Antibodies
•    The Impact of Digital Technologies on Point-of-Care Diagnostics in Resource-Limited Settings.
•    The Challenges and Some Emerging Strategies for Tackling a Global Bacterial Menace
•    Biosensors for the Detection of Bacterial and Viral Clinical Pathogens
•    Electrochemical Diagnostics of Infectious Viral Diseases 
 

Stay Updated: The conference provides a platform to gain insights into the latest advancements, trends, and innovations in infectious disease diagnostics and molecular diagnostics.

Networking Opportunities: With 120+ professionals attending the conference provides an excellent opportunity to network, forge valuable connections, and collaborate with like-minded individuals who share a passion for diagnostics and healthcare.

Knowledge Exchange: The conference features discussions, presentations, and interactive sessions led by industry experts and thought leaders.

Emerging Technologies: The conference focuses on trending technologies in diagnostics and their applications. By attending, you can gain insights into emerging tools, platforms, and methodologies that can enhance diagnostic accuracy, speed, and precision.

Address Challenges: The conference addresses challenges faced in the diagnostics field. By participating, you can learn about potential solutions and best practices to overcome these hurdles in the diagnostics world.

Global Healthcare Perspectives: The conference examines the need for improved healthcare worldwide and explores how diagnostics can contribute to this goal. You can gain a broader understanding of the global healthcare landscape and discover ways to facilitate better healthcare outcomes on a global scale.

Vaccine Insights: The event also covers topics related to vaccine efficacy, side effects, and their impact on diagnostics.

Hospitals/Universities/Labs

  • Hospitals - Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department, Molecular Biology, Molecular Genetics
  • Hospital Designations - Senior scientist, scientist, Microbiologist, biologists, pathologist, General
  • Practitioners, Lab managers, Lab directors, medical directors, POCT coordinators
  • Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors
  • Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Clinicians
  • Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening remarks from the Chairman

Andrew Benson

Andrew Benson, Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc

08:55 - 09:00

ADAPTING MOLECULAR DIAGNOSTICS FOR EVOLVING DISEASES

Keynote Presentation -The Co-Dx PCR platform: the future of accessible diagnostics

Dwight Egan

Dwight Egan, Chief Executive Officer, Co-Diagnostics, Inc

09:00 - 09:30

Developing a Molecular and Rapid Testing Diagnostic Service

Stuart Whitmore

Stuart Whitmore, Molecular Laboratory Manager, East Suffolk and North Essex NHS Foundation Trust

09:30 - 10:00

Skip to the good bit - Prepyx® Extraction-Free Buffer

Nicole Ball

Nicole Ball, Application Specialist (Molecular), R-Biopharm Rhône Ltd

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:20

The universal one workflow in PCR multiplex testing

Jennifer Juwah

Jennifer Juwah, UK Business Manager - Molecular Biology, Eurobio Scientific UK

11:20 - 11:50

REDESIGNING DIAGNOSTICS WITH NEXT-GEN TECHNOLOGIES

Antimicrobial Resistance and Testing

Helen Dent

Helen Dent, CEO, BIVDA Helen Dent

11:50 - 12:20

The Devil is in the Data

Eimear Malone

Eimear Malone, Molecular Product Specialist, Randox Laboratories

12:20 - 12:50

Lateral flow and molecular diagnostics - the best of both worlds

Nina Garrett

Nina Garrett, Chief Technical Officer, Abingdon Health

12:50 - 13:20

Lunch and Poster Presentation | One-to-One Networking Meetings

13:20 - 14:20

Unlocking the Potential of CandID in the Diagnosis of Invasive Candidiasis

Gemma Johnson

Gemma Johnson, Scientific Director, OLM Diagnostics

14:20 - 14:50

SHAPING THE CUSTOMIZED MODEL’S AND ADVANCEMENTS IN POINT OF CARE TESTING FOR INFECTIOUS DISEASE DIAGNOSTICS

Rapid Diagnostic Workflow in the Sepsis

Adriana Calderaro

Adriana Calderaro, Full Professor of Clinical Microbiology, University Hospital of Parma

14:50 - 15:20

Modern Tools for Rapid Diagnostics of Antimicrobial Resistance

Dushyanthie Athukorala

Dushyanthie Athukorala, Consultant in Microbiology, UHCW NHS Trust

15:20 - 15:50

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:50 - 16:30

ENCOURAGING DIAGNOSTIC TECHNIQUES IN THE ERA OF CONSOLIDATION

Blood Borne Virus Screen (BBV) testing in emergency departments – Pathology perspective

Dipti Patel

Dipti Patel, Infection and Immunity Lead | Scientist/Manager, Imperial College Healthcare NHS Trust

16:30 - 17:00

Reworking qPCR for extreme and point-of-care applications Demonstration of low denaturation, high polymerisation temperature qPCR Demonstration of extreme PCR completing 30 cycles in less than 2 minutes

Stephen Bustin

Stephen Bustin, Professor of Molecular Medicine, Medical Technology Research Centre, Anglia Ruskin University, UK

17:00 - 17:30

Closing Remarks from the Chairperson

Andrew Benson

Andrew Benson, Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc

17:30 - 17:30

Drinks Reception & Networking End of Day 1

17:30 - 17:30

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening remarks from the Chairman

Andrew Benson

Andrew Benson, Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc

08:55 - 09:00

FUTURE MOLECULAR DIAGNOSTICS AND NEW DIAGNOSTIC TECHNOLOGIES

Keynote Presentation: Accessible TB Diagnostics on the Co-Dx PCR Pro in LMICs

Joseph Featherstone

Joseph Featherstone, Head of Business Development, Co-Diagnostics, Inc

09:00 - 09:30

Technological advances in Infectious Diseases diagnostics: New lamps for Old?

Elfatih Mustafa Awadel-Kariem

Elfatih Mustafa Awadel-Kariem, Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust

09:30 - 10:00

Emerging Challenges in the Diagnosis of Azole-Resistant Invasive Aspergillosis

Paul E. Verweij

Paul E. Verweij, Professor of Clinical Mycology, Radboud University Nijmegen Medical Center

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:20

Screening for Immunity to Support Vaccination Strategies

Jennifer Heaney

Jennifer Heaney, Researcher, University of Birmingham

11:20 - 11:50

SHAPING THE POINT OF CARE ERA WITH BEST TOOLS AND METHODOLOGIES

Utility of Artificial Intelligence (AI) in management of infectious diseases

Peter Munthali

Peter Munthali , Consultant- Bacteriology · Microbiology, University Hospital Coventry

11:50 - 12:20

Design and proof of principle in a mouse model of a promising vaccine for Zika virus that is currently in phase I clinical trial

Thomas Blanchard

Thomas Blanchard, Consultant in Infectious Disease, Liverpool University Hospitals NHS Foundation Trust

12:20 - 12:50

Lunch and Poster Presentation | One-to-One Networking Meetings

12:45 - 13:50

WGS as a Proactive Tool for Cutting Down Healthcare-Associated Transmission of Infections

Susie Jerwood

Susie Jerwood, Medical Microbiologist,

13:50 - 14:20

Panel Discussion: Virology Remains a Rapidly Changing Field and the Diagnostic Clinical Laboratory must keep Abreast of newer Viruses, Targets and Technologies

Susie Jerwood

Susie Jerwood, Medical Microbiologist,

Stephen Bustin

Stephen Bustin, Professor of Molecular Medicine, Medical Technology Research Centre, Anglia Ruskin University, UK

Elfatih Mustafa Awadel-Kariem

Elfatih Mustafa Awadel-Kariem, Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust

Thomas Blanchard

Thomas Blanchard, Consultant in Infectious Disease, Liverpool University Hospitals NHS Foundation Trust

14:20 - 15:00

Closing Remarks from the Chairperson

Andrew Benson

Andrew Benson, Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc

15:00 - 15:00

End of Conference

15:00 - 15:00

SPEAKERS

Helen Dent

Helen Dent

CEO, BIVDA Helen Dent

Nicole Ball

Nicole Ball

Application Specialist (Molecular), R-Biopharm Rhône Ltd

Andrew Benson

Andrew Benson

Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc

Gemma Johnson

Gemma Johnson

Scientific Director, OLM Diagnostics

Paul E. Verweij

Paul E. Verweij

Professor of Clinical Mycology, Radboud University Nijmegen Medical Center

Susie Jerwood

Susie Jerwood

Medical Microbiologist,

Dipti Patel

Dipti Patel

Infection and Immunity Lead | Scientist/Manager, Imperial College Healthcare NHS Trust

Stephen Bustin

Stephen Bustin

Professor of Molecular Medicine, Medical Technology Research Centre, Anglia Ruskin University, UK

Jennifer Heaney

Jennifer Heaney

Researcher, University of Birmingham

Dushyanthie Athukorala

Dushyanthie Athukorala

Consultant in Microbiology, UHCW NHS Trust

Joseph Featherstone

Joseph Featherstone

Head of Business Development, Co-Diagnostics, Inc

Stuart Whitmore

Stuart Whitmore

Molecular Laboratory Manager, East Suffolk and North Essex NHS Foundation Trust

Peter Munthali

Peter Munthali

Consultant- Bacteriology · Microbiology, University Hospital Coventry

Elfatih Mustafa Awadel-Kariem

Elfatih Mustafa Awadel-Kariem

Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust

Rocio T. Martinez Nunez

Rocio T. Martinez Nunez

Senior Lecturer, Dept. Infectious Diseases, School of Immunology & Microbial Sciences, King College London

Eimear Malone

Eimear Malone

Molecular Product Specialist, Randox Laboratories

Adriana Calderaro

Adriana Calderaro

Full Professor of Clinical Microbiology, University Hospital of Parma

Nina Garrett

Nina Garrett

Chief Technical Officer, Abingdon Health

Senior Representative, Eurobio Scientific

Senior Representative, Eurobio Scientific

,

ENQUIRE NOW

SPONSORS

LOCATION

Venue

Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH

PAST EVENT GALLERY